Tissue polypeptide antigen (TPA): usefulness in urological neoplasia. 1986

C B Costello, and S Kumar

Urine and serum samples from a group of 359 individuals were studied in order to evaluate the usefulness of TPA in patients with urological cancers. Serum was taken from 110 people at 12 noon (S1), 5 pm (S2), and 8 am the following day (S3), while urine samples were collected from 73 individuals over three time intervals: 8 am to 12 noon (U1), 12 noon to 5 pm (U2), and 5 pm to 8 am the following morning (U3). In addition, there were 24-hour urine samples from 176 persons. TPA concentrations in S1, S2, or S3 were not correlated with the presence of a tumor. In contrast, good correlation was observed between TPA concentrations in U1, U2, or U3 and disease status and an even better correlation existed between TPA in 24-hour urine samples and disease status. It is proposed that the judicious use of 24-hour urinary TPA levels should prove valuable in monitoring the course of urological cancers.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D014571 Urologic Neoplasms Tumors or cancer of the URINARY TRACT in either the male or the female. Cancer of Urinary Tract,Urinary Tract Cancer,Urologic Cancer,Cancer of the Urinary Tract,Neoplasms, Urologic,Urinary Tract Neoplasms,Urological Cancer,Urological Neoplasms,Cancer, Urinary Tract,Cancer, Urologic,Cancer, Urological,Cancers, Urinary Tract,Cancers, Urologic,Cancers, Urological,Neoplasm, Urinary Tract,Neoplasm, Urologic,Neoplasm, Urological,Neoplasms, Urinary Tract,Neoplasms, Urological,Tract Neoplasm, Urinary,Tract Neoplasms, Urinary,Urinary Tract Cancers,Urinary Tract Neoplasm,Urologic Cancers,Urologic Neoplasm,Urological Cancers,Urological Neoplasm
D019396 Tissue Polypeptide Antigen Serological tumor marker composed of a molecular complex of cytokeratins 8, 18, and 19. It is used in the diagnosis and staging of bronchogenic carcinoma. TPA Antigen,Antigen, TPA,Antigen, Tissue Polypeptide

Related Publications

C B Costello, and S Kumar
December 1983, Hinyokika kiyo. Acta urologica Japonica,
C B Costello, and S Kumar
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
C B Costello, and S Kumar
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
C B Costello, and S Kumar
December 1985, Hinyokika kiyo. Acta urologica Japonica,
C B Costello, and S Kumar
February 1977, Lakartidningen,
C B Costello, and S Kumar
February 1987, Tumori,
C B Costello, and S Kumar
January 1989, The International journal of biological markers,
C B Costello, and S Kumar
June 1984, Journal of endocrinological investigation,
C B Costello, and S Kumar
January 1984, Revista espanola de oncologia,
C B Costello, and S Kumar
November 1985, British journal of cancer,
Copied contents to your clipboard!